Fujian Akeylink Biotechnology Co., Ltd.
Registry sponsor category
Industry
- Other names
- Fujian Akeylink Biotechnology Co., Ltd.
- Company name
- Fujian Akeylink Biotechnology Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (12)
- A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
- Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
- Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets
- Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants
- Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function
- Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function
- Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B
- Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets
- Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets
- Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
- Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
- To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment